PMC:7105881 / 35496-35743 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1122","span":{"begin":210,"end":214},"obj":"Species"},{"id":"1123","span":{"begin":233,"end":241},"obj":"Species"},{"id":"1128","span":{"begin":76,"end":87},"obj":"Species"},{"id":"1131","span":{"begin":7,"end":25},"obj":"Disease"}],"attributes":[{"id":"A1122","pred":"tao:has_database_id","subj":"1122","obj":"Tax:10090"},{"id":"A1123","pred":"tao:has_database_id","subj":"1123","obj":"Tax:694009"},{"id":"A1128","pred":"tao:has_database_id","subj":"1128","obj":"Tax:575864"},{"id":"A1131","pred":"tao:has_database_id","subj":"1131","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"gainst SARS-CoV infection (Guo et al., 2005; Li et al., 2013). For example, recombinant S1 proteins fused with or without foldon elicited specific antibodies with neutralizing activity that protected immunized mice against high-dose SARS-CoV chall"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T202","span":{"begin":91,"end":99},"obj":"Body_part"}],"attributes":[{"id":"A202","pred":"fma_id","subj":"T202","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"gainst SARS-CoV infection (Guo et al., 2005; Li et al., 2013). For example, recombinant S1 proteins fused with or without foldon elicited specific antibodies with neutralizing activity that protected immunized mice against high-dose SARS-CoV chall"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T195","span":{"begin":7,"end":25},"obj":"Disease"},{"id":"T196","span":{"begin":16,"end":25},"obj":"Disease"},{"id":"T197","span":{"begin":233,"end":241},"obj":"Disease"}],"attributes":[{"id":"A195","pred":"mondo_id","subj":"T195","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A196","pred":"mondo_id","subj":"T196","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A197","pred":"mondo_id","subj":"T197","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"gainst SARS-CoV infection (Guo et al., 2005; Li et al., 2013). For example, recombinant S1 proteins fused with or without foldon elicited specific antibodies with neutralizing activity that protected immunized mice against high-dose SARS-CoV chall"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T464","span":{"begin":45,"end":47},"obj":"http://purl.obolibrary.org/obo/CLO_0001022"},{"id":"T465","span":{"begin":45,"end":47},"obj":"http://purl.obolibrary.org/obo/CLO_0007314"},{"id":"T466","span":{"begin":88,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T467","span":{"begin":176,"end":184},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"gainst SARS-CoV infection (Guo et al., 2005; Li et al., 2013). For example, recombinant S1 proteins fused with or without foldon elicited specific antibodies with neutralizing activity that protected immunized mice against high-dose SARS-CoV chall"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T206","span":{"begin":27,"end":30},"obj":"Chemical"},{"id":"T207","span":{"begin":45,"end":47},"obj":"Chemical"},{"id":"T208","span":{"begin":91,"end":99},"obj":"Chemical"}],"attributes":[{"id":"A206","pred":"chebi_id","subj":"T206","obj":"http://purl.obolibrary.org/obo/CHEBI_16750"},{"id":"A207","pred":"chebi_id","subj":"T207","obj":"http://purl.obolibrary.org/obo/CHEBI_30145"},{"id":"A208","pred":"chebi_id","subj":"T208","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"gainst SARS-CoV infection (Guo et al., 2005; Li et al., 2013). For example, recombinant S1 proteins fused with or without foldon elicited specific antibodies with neutralizing activity that protected immunized mice against high-dose SARS-CoV chall"}

{"project":"2_test","denotations":[{"id":"32265848-16101349-36511148","span":{"begin":39,"end":43},"obj":"16101349"},{"id":"32265848-23573979-36511149","span":{"begin":56,"end":60},"obj":"23573979"}],"text":"gainst SARS-CoV infection (Guo et al., 2005; Li et al., 2013). For example, recombinant S1 proteins fused with or without foldon elicited specific antibodies with neutralizing activity that protected immunized mice against high-dose SARS-CoV chall"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T605","span":{"begin":7,"end":15},"obj":"SP_10"},{"id":"T606","span":{"begin":147,"end":157},"obj":"GO:0042571"},{"id":"T607","span":{"begin":210,"end":214},"obj":"NCBITaxon:10088"},{"id":"T608","span":{"begin":233,"end":241},"obj":"SP_10"},{"id":"T86425","span":{"begin":7,"end":15},"obj":"SP_10"},{"id":"T21173","span":{"begin":147,"end":157},"obj":"GO:0042571"},{"id":"T4815","span":{"begin":210,"end":214},"obj":"NCBITaxon:10088"},{"id":"T43943","span":{"begin":233,"end":241},"obj":"SP_10"}],"text":"gainst SARS-CoV infection (Guo et al., 2005; Li et al., 2013). For example, recombinant S1 proteins fused with or without foldon elicited specific antibodies with neutralizing activity that protected immunized mice against high-dose SARS-CoV chall"}